Avastus Preclinical Services
Private Company
Funding information not available
Overview
Avastus Preclinical Services is a private, revenue-generating CRO and vivarium services provider headquartered in Cambridge, Massachusetts, with a significant 30,000 sq ft facility. Its business model is centered on providing flexible, outsourced preclinical research infrastructure and services, including access to advanced in vivo imaging via a partnership with Revvity. The company serves a broad client base from startups to large multinationals, supporting drug development across multiple therapeutic areas through animal model studies, assay development, and proof-of-concept work.
Technology Platform
Integrated preclinical service infrastructure featuring vivarium space, procedure rooms, and access to Revvity's advanced in vivo imaging platforms for non-invasive, real-time tracking of disease and therapeutic response.
Opportunities
Risk Factors
Competitive Landscape
Avastus competes in the fragmented preclinical CRO and vivarium services market. Key competitors include large public CROs like Charles River Laboratories and Labcorp, which offer global scale, as well as numerous regional/specialty providers and academic core facilities in the Boston area. Avastus differentiates through its flexible hybrid model, Cambridge location, and Revvity imaging partnership.